>
Organization
Pharmacyclics LLC
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Pharmacyclics LLC

... Pharmaceutical Company Limited. Previously, Mr. Soni served as Chief Financial Officer of Pharmacyclics, Inc., a publicly-held biopharmaceutical company, until its acquisition by AbbVie, Inc. in ...
... and NRG Oncology, and was sponsored by the NCI in collaboration with Pharmacyclics LLC, an AbbVie company, through the existing Cooperative Research and Development Agreement ...
... inhibitor that is administered orally, and is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc. "iLLUMINATE represents one of ...
... inhibitor that is administered orally, and is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc. "With up to seven ...
... its research center in Redwood City and the homes of its subsidiaries Pharmacyclics and Stemcentrx. Ground was broken for the project in May 2017and is ...
... $18.4 billion last year, and snapped up co-marketing rights to Imbruvica from Pharmacyclics in a $21 billion deal. Analysts believe Humira will pass the $20 ...
... inhibitor that is administered orally, and is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc. "Our robust clinical research ...
... to Kite Pharma, Mr. Suchet served as Vice President of IT at Pharmacyclics Inc., a clinical stage and commercial biopharmaceutical company. As a member of ...
... Night, thousands of national partners, sponsors and corporate teams, including Burlington Stores, Pharmacyclics, Janssen, Walgreens and Wawa, are helping LLS fund lifesaving research and support ...
... kinase (BTK) inhibitor jointly developed and commercialized by Janssen Biotech, Inc. and Pharmacyclics LLC, an AbbVie company. 'The combination of IMBRUVICA and rituximab provides health ...
Subscribe now for full coverage on Pharmacyclics LLC
Start My Free Trial